Tamura K - Search Results

1

Localization of tumor suppressor activity important in nonsmall cell lung carcinoma on chromosome 11q.

Murakami Y, Nobukuni T, Tamura K, Maruyama T, Sekiya T, Arai Y, Gomyou H, Tanigami A, Ohki M, Cabin D, Frischmeyer P, Hunt P, Reeves RH. Murakami Y, et al. Among authors: tamura k. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8153-8. doi: 10.1073/pnas.95.14.8153. Proc Natl Acad Sci U S A. 1998. PMID: 9653156 Free PMC article.

2

Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer.

Tamura K, Zhang X, Murakami Y, Hirohashi S, Xu HJ, Hu SX, Benedict WF, Sekiya T. Tamura K, et al. Int J Cancer. 1997 Feb 20;74(1):45-9. doi: 10.1002/(sici)1097-0215(19970220)74:1<45::aid-ijc8>3.0.co;2-0. Int J Cancer. 1997. PMID: 9036868

3

Homozygous deletion on the chromosomal region 5q12.3 in human lines of small-cell lung cancers.

Tamura K, Miwa W, Maruyama T, Sekiya T, Murakami Y. Tamura K, et al. J Hum Genet. 2002;47(7):348-54. doi: 10.1007/s100380200048. J Hum Genet. 2002. PMID: 12111368

4

Mathematical analysis of gefitinib resistance of lung adenocarcinoma caused by MET amplification.

Ito T, Kumagai Y, Itano K, Maruyama T, Tamura K, Kawasaki S, Suzuki T, Murakami Y. Ito T, et al. Among authors: tamura k. Biochem Biophys Res Commun. 2019 Apr 9;511(3):544-550. doi: 10.1016/j.bbrc.2019.02.086. Epub 2019 Feb 26. Biochem Biophys Res Commun. 2019. PMID: 30824185

5

Gefitinib in non-small cell lung cancer.

Tamura K, Fukuoka M. Tamura K, et al. Expert Opin Pharmacother. 2005 Jun;6(6):985-93. doi: 10.1517/14656566.6.6.985. Expert Opin Pharmacother. 2005. PMID: 15952926 Review.

6

Phase I/II study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer.

Tamura K, Okamoto I, Ozaki T, Kashii T, Takeda K, Kobayashi M, Matsui K, Shibata T, Kurata T, Nakagawa K, Fukuoka M. Tamura K, et al. Eur J Cancer. 2009 Aug;45(12):2132-7. doi: 10.1016/j.ejca.2009.04.003. Epub 2009 May 4. Eur J Cancer. 2009. PMID: 19409773 Clinical Trial.

7

Expanding the clinicopathologic and molecular spectrum of BCOR-associated sarcomas in adults.

Yoshida A, Arai Y, Hama N, Chikuta H, Bando Y, Nakano S, Kobayashi E, Shibahara J, Fukuhara H, Komiyama M, Watanabe SI, Tamura K, Kawai A, Shibata T. Yoshida A, et al. Among authors: tamura k. Histopathology. 2020 Mar;76(4):509-520. doi: 10.1111/his.14023. Epub 2020 Feb 21. Histopathology. 2020. PMID: 31647130

8

[Development of new molecular target drug].

Tamura K. Tamura K. Gan To Kagaku Ryoho. 2010 Aug;37(8):1467-70. Gan To Kagaku Ryoho. 2010. PMID: 20860098 Japanese. No abstract available.

9

Amrubicin for non-small-cell lung cancer and small-cell lung cancer.

Kurata T, Okamoto I, Tamura K, Fukuoka M. Kurata T, et al. Among authors: tamura k. Invest New Drugs. 2007 Oct;25(5):499-504. doi: 10.1007/s10637-007-9069-0. Epub 2007 Jul 13. Invest New Drugs. 2007. PMID: 17628745 Review.

10

Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma.

Kondo S, Ojima H, Tsuda H, Hashimoto J, Morizane C, Ikeda M, Ueno H, Tamura K, Shimada K, Kanai Y, Okusaka T. Kondo S, et al. Among authors: tamura k. Int J Clin Oncol. 2013 Apr;18(2):207-13. doi: 10.1007/s10147-011-0361-9. Epub 2012 Jan 5. Int J Clin Oncol. 2013. PMID: 22218908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,401 results

Search Page

Filters